Blood Monitoring Patents For Drug Dosages Rejected By Supreme Court – Huffington Post
"We conclude that the patent claims at issue here effectively claim the underlying laws of nature themselves. The claims are consequently invalid," Breyer wrote in the 24-page opinion. The biotech industry warned the Supreme Court's ruling could ...
Subscribe to LegalLaw247.Com Newsletter